| Over a week ago |
|
Hot Stocks
|
Univar Solutions Brasil,… Univar Solutions Brasil, a subsidiary of Univar Solutions, announced an expanded distribution relationship in Brazil with Dow. The new agreement will strengthen Univar Solutions' homecare & industrial cleaning portfolio in Brazil with the addition of cleaning brands ACUSOL, SupraCare, and others. Univar Solutions and Dow Expand Relationship in Brazil to Include the Homecare and Industrial Cleaning Market"Our enhanced partnership with Dow represents a major step for our homecare and industrial cleaning business in Brazil. Building on our close collaboration with Dow in North America and Europe, the new agreement will increase the depth and breadth of our portfolio and customer reach in this region, and demonstrates the importance of strong global supplier relationships," said Jorge Buckup, president, Latin America for Univar Solutions. Univar Solutions' customers in Brazil will have access to Dow brands that are used in home and industrial cleaning applications and products such as dish, laundry, and surface cleaners. ShowHide Related Items >><< - 01/24/23
- Univar named as distributor for Dow's acrylic emulsion polymer products
- 01/23/23
- Univar to acquire Turkish specialty chemicals distributor Kale Kimya, no terms
- 01/11/23
- Univar up 3% after Bloomberg report on PE bidder interest
- 01/03/23
- Brenntag terminates preliminary discussions with Univar
- 10/26/22
- Novonix appoints Daniel Akerson, Ron Edmonds to board of directors
- 10/20/22
- Dow Inc. expects dynamic macro environment in the near term
- 10/17/22
- Dow Inc. to accelerate sustainability targets the company set in 2020
- 01/11/23
- BofA shakes up ratings to get 'more offensive' in U.S. Chemicals
- 01/11/23 BofA
- Univar downgraded to Underperform from Buy at BofA
- 01/03/23 Oddo BHF
- Brenntag upgraded to Outperform from Neutral at Oddo BHF
- 11/29/22 Deutsche Bank
- Univar buyout could bring 'substantial upside,' says Deutsche Bank
- 01/17/23 Fermium Research
- Dow Inc. downgraded to Hold from Buy at Fermium Research
- 01/12/23 KeyBanc
- Dow Inc. price target raised to $51 from $39 at KeyBanc
- 01/11/23 BofA
- Dow Inc. upgraded to Neutral from Underperform at BofA
- 11/01/22
- Univar sees FY22 adjusted EBITDA $1.050B-$1.070B
- 11/01/22
- Univar sees Q4 adjusted EBITDA $180M-$200M
- 11/01/22
- Univar reports Q3 EPS 78c, consensus 76c
- 08/01/22
- Univar sees FY22 adjusted EBITDA $1.040B-$1.080B
- 10/20/22
- Dow Inc. reports Q3 operating EPS $1.11, consensus $1.08
- 09/14/22
- Dow Inc. sees $600M lower Q3 net sales compared to consensus
- 01/11/23
- Univar draws interest from Apollo, Platinum Equity, Bloomberg says
- 01/03/23
- What You Missed On Wall Street On Tuesday
- 11/28/22
- What You Missed On Wall Street On Monday
- 11/28/22
- What You Missed On Wall Street This Morning
- 10/21/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 09/20/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 09/14/22
- What You Missed On Wall Street On Wednesday
- 09/14/22
- What You Missed On Wall Street This Morning
- 09/14/22
- Fly Intel: Pre-market Movers
- 01/10/23
- Dow Chemical put volume heavy and directionally bearish
- 01/04/23
- Dow Chemical call volume above normal and directionally bullish
- 11/11/22
- Early notable gainers among liquid option names on November 11th
- 09/14/22
- Dow Chemical put volume heavy and directionally bearish
|
|
Initiation
|
Morgan Stanley analyst… Morgan Stanley analyst Annelies Vermeulen initiated coverage of Brenntag with an Overweight rating and EUR 85 price target. The analyst thinks the company "can surprise with more resilient performance" as growth and margins taper across the space in 2023. ShowHide Related Items >><< - 01/03/23
- Brenntag terminates preliminary discussions with Univar
- 01/03/23
- Univar confirms Brenntag talks ended, weighing other interest
- 11/28/22
- Univar confirms preliminary indication of interest from Brenntag
- 11/25/22
- Brenntag says in preliminary talks to acquire Univar
- 01/10/23 Goldman Sachs
- Brenntag reinstated with a Buy at Goldman Sachs
- 01/03/23 Oddo BHF
- Brenntag upgraded to Outperform from Neutral at Oddo BHF
- 11/29/22 Deutsche Bank
- Univar buyout could bring 'substantial upside,' says Deutsche Bank
- 11/29/22 Citi
- Brenntag downgraded to Neutral from Buy at Citi
- 11/28/22
- What You Missed On Wall Street On Monday
- 11/28/22
- What You Missed On Wall Street This Morning
|
|
Hot Stocks
|
Univar Solutions B.V., a… Univar Solutions B.V., a subsidiary of Univar Solutions (UNVR), announced the company has been named as a distributor for Dow's (DOW) acrylic emulsion polymer products included in the PRIMAL and UCAR LATEX brand portfolios in the United Kingdom and Ireland. PRIMAL and UCAR LATEX products are used in construction for improving the properties of cementitious as well as non-cementitious applications. ShowHide Related Items >><< - 01/23/23
- Univar to acquire Turkish specialty chemicals distributor Kale Kimya, no terms
- 01/11/23
- Univar up 3% after Bloomberg report on PE bidder interest
- 01/03/23
- Brenntag terminates preliminary discussions with Univar
- 01/03/23
- Univar confirms Brenntag talks ended, weighing other interest
- 10/26/22
- Novonix appoints Daniel Akerson, Ron Edmonds to board of directors
- 10/20/22
- Dow Inc. expects dynamic macro environment in the near term
- 10/17/22
- Dow Inc. to accelerate sustainability targets the company set in 2020
- 09/14/22
- Dow an Mura plan to construct new facility at Bohlen
- 01/11/23
- BofA shakes up ratings to get 'more offensive' in U.S. Chemicals
- 01/11/23 BofA
- Univar downgraded to Underperform from Buy at BofA
- 01/03/23 Oddo BHF
- Brenntag upgraded to Outperform from Neutral at Oddo BHF
- 11/29/22 Deutsche Bank
- Univar buyout could bring 'substantial upside,' says Deutsche Bank
- 01/17/23 Fermium Research
- Dow Inc. downgraded to Hold from Buy at Fermium Research
- 01/12/23 KeyBanc
- Dow Inc. price target raised to $51 from $39 at KeyBanc
- 01/11/23 BofA
- Dow Inc. upgraded to Neutral from Underperform at BofA
- 11/01/22
- Univar sees FY22 adjusted EBITDA $1.050B-$1.070B
- 11/01/22
- Univar sees Q4 adjusted EBITDA $180M-$200M
- 11/01/22
- Univar reports Q3 EPS 78c, consensus 76c
- 08/01/22
- Univar sees FY22 adjusted EBITDA $1.040B-$1.080B
- 10/20/22
- Dow Inc. reports Q3 operating EPS $1.11, consensus $1.08
- 09/14/22
- Dow Inc. sees $600M lower Q3 net sales compared to consensus
- 01/11/23
- Univar draws interest from Apollo, Platinum Equity, Bloomberg says
- 01/03/23
- What You Missed On Wall Street On Tuesday
- 11/28/22
- What You Missed On Wall Street On Monday
- 11/28/22
- What You Missed On Wall Street This Morning
- 10/21/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 09/20/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 09/14/22
- What You Missed On Wall Street On Wednesday
- 09/14/22
- What You Missed On Wall Street This Morning
- 09/14/22
- Fly Intel: Pre-market Movers
- 01/10/23
- Dow Chemical put volume heavy and directionally bearish
- 01/04/23
- Dow Chemical call volume above normal and directionally bullish
- 11/11/22
- Early notable gainers among liquid option names on November 11th
- 09/14/22
- Dow Chemical put volume heavy and directionally bearish
|
|
Hot Stocks
|
Univar Solutions… Univar Solutions announced that it has signed an agreement to acquire leading Turkish specialty chemicals distributor Kale Kimya. Terms of the transaction were not disclosed. Closing of the acquisition is subject to certain regulatory approvals and is expected to be completed within Q1 2023. ShowHide Related Items >><< - 01/11/23
- Univar up 3% after Bloomberg report on PE bidder interest
- 01/03/23
- Brenntag terminates preliminary discussions with Univar
- 01/03/23
- Univar confirms Brenntag talks ended, weighing other interest
- 12/15/22
- Univar and Kalsec expand distribution partnership for ingredient solutions
- 01/11/23
- BofA shakes up ratings to get 'more offensive' in U.S. Chemicals
- 01/11/23 BofA
- Univar downgraded to Underperform from Buy at BofA
- 01/03/23 Oddo BHF
- Brenntag upgraded to Outperform from Neutral at Oddo BHF
- 11/29/22 Deutsche Bank
- Univar buyout could bring 'substantial upside,' says Deutsche Bank
- 11/01/22
- Univar sees FY22 adjusted EBITDA $1.050B-$1.070B
- 11/01/22
- Univar sees Q4 adjusted EBITDA $180M-$200M
- 11/01/22
- Univar reports Q3 EPS 78c, consensus 76c
- 08/01/22
- Univar sees FY22 adjusted EBITDA $1.040B-$1.080B
- 01/11/23
- Univar draws interest from Apollo, Platinum Equity, Bloomberg says
- 01/03/23
- What You Missed On Wall Street On Tuesday
- 11/28/22
- What You Missed On Wall Street On Monday
- 11/28/22
- What You Missed On Wall Street This Morning
- 10/21/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
|
|
Hot Stocks
| ShowHide Related Items >><< - 01/03/23
- Brenntag terminates preliminary discussions with Univar
- 01/03/23
- Univar confirms Brenntag talks ended, weighing other interest
- 12/15/22
- Univar and Kalsec expand distribution partnership for ingredient solutions
- 11/30/22
- Engine Capital sends letter to Univar board requesting initiation of review
- 01/11/23
- BofA shakes up ratings to get 'more offensive' in U.S. Chemicals
- 01/11/23 BofA
- Univar downgraded to Underperform from Buy at BofA
- 01/03/23 Oddo BHF
- Brenntag upgraded to Outperform from Neutral at Oddo BHF
- 11/29/22 Deutsche Bank
- Univar buyout could bring 'substantial upside,' says Deutsche Bank
- 11/01/22
- Univar sees FY22 adjusted EBITDA $1.050B-$1.070B
- 11/01/22
- Univar sees Q4 adjusted EBITDA $180M-$200M
- 11/01/22
- Univar reports Q3 EPS 78c, consensus 76c
- 08/01/22
- Univar sees FY22 adjusted EBITDA $1.040B-$1.080B
- 01/11/23
- Univar draws interest from Apollo, Platinum Equity, Bloomberg says
- 01/03/23
- What You Missed On Wall Street On Tuesday
- 11/28/22
- What You Missed On Wall Street On Monday
- 11/28/22
- What You Missed On Wall Street This Morning
- 10/21/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
|
|
Periodicals
|
Chemical distributor… Chemical distributor Univar Solutions (UNVR) is drawing interest from potential bidders that include Apollo Global (APO) and Platinum Equity, sources familiar with matter tell Bloomberg's Kiel Porter. ShowHide Related Items >><< - 01/03/23
- Brenntag terminates preliminary discussions with Univar
- 01/03/23
- Univar confirms Brenntag talks ended, weighing other interest
- 12/15/22
- Univar and Kalsec expand distribution partnership for ingredient solutions
- 11/30/22
- Engine Capital sends letter to Univar board requesting initiation of review
- 12/27/22
- Apollo Global names Tatsuo Tanaka as Japan Chair
- 12/15/22
- Apollo funds provide $200M to WEC Energy renewable porfolio
- 11/29/22
- Atlas Air Worldwide shareholders approve of proposed acquisition by Apollo
- 11/29/22
- Apollo Global appoints Wooden as Partner, Chief Public Pension Strategist
- 01/11/23
- BofA shakes up ratings to get 'more offensive' in U.S. Chemicals
- 01/11/23 BofA
- Univar downgraded to Underperform from Buy at BofA
- 01/03/23 Oddo BHF
- Brenntag upgraded to Outperform from Neutral at Oddo BHF
- 11/29/22 Deutsche Bank
- Univar buyout could bring 'substantial upside,' says Deutsche Bank
- 01/02/23 Keefe Bruyette
- Apollo Global downgraded to Market Perform from Outperform at Keefe Bruyette
- 12/19/22 Barclays
- Apollo Global price target raised to $78 from $73 at Barclays
- 11/15/22 Deutsche Bank
- Apollo Global price target raised to $83 from $81 at Deutsche Bank
- 11/03/22 Barclays
- Apollo Global price target raised to $73 from $65 at Barclays
- 11/01/22
- Univar sees FY22 adjusted EBITDA $1.050B-$1.070B
- 11/01/22
- Univar sees Q4 adjusted EBITDA $180M-$200M
- 11/01/22
- Univar reports Q3 EPS 78c, consensus 76c
- 08/01/22
- Univar sees FY22 adjusted EBITDA $1.040B-$1.080B
- 11/02/22
- Apollo Global reports Q3 EPS ($1.52) vs. $1.01 last year
- 11/01/22
- Notable companies reporting before tomorrow's open
- 08/04/22
- Apollo Global reports Q2 adjusted EPS 94c, consensus $1.02
- 12/16/22
- Avaya nearing Chapter 11 bankruptcy filing, WSJ reports
- 12/15/22
- Apollo, EQT sell Direct ChassisLink for roughly $3.6B, Reuters reports
- 12/06/22
- Apollo, Pimco sign deal to act together in Carvana debt talks, Bloomberg says
- 11/29/22
- Yahoo eyes sports betting, retail stock trading, Axios reports
- 01/03/23
- What You Missed On Wall Street On Tuesday
- 11/28/22
- What You Missed On Wall Street On Monday
- 11/28/22
- What You Missed On Wall Street This Morning
- 10/21/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/16/22
- What You Missed On Wall Street This Morning
- 12/07/22
- What You Missed On Wall Street This Morning
- 11/29/22
- What You Missed On Wall Street This Morning
- 01/09/23
- Apollo Global put volume heavy and directionally bearish
- 12/28/22
- Apollo Global put volume heavy and directionally bearish
- 12/22/22
- Apollo Global put volume heavy and directionally bearish
- 12/07/22
- Apollo Global put volume heavy and directionally bearish
|
|
Recommendations
|
BofA analysts Matthew… BofA analysts Matthew DeYoe and Steve Byrne are shaking up their ratings in the U.S. Chemicals space to take a "more offensive stance," while refraining from going "all in" on risk assets until they see more confirmation from macro and commodity markets, they tell investors in a sector note. In that context, the team upgraded Chemours (CC) and Eastman Chemical (EMN) to Buy from Neutral, double upgraded Livent (LTHM) to Buy from Underperform, and raised both Dow Inc. (DOW) and Corteva (CTVA) to Neutral from Underperform. Meanwhile, to keep at least 20% of their coverage at Underperform, they downgraded Univar (UNVR) to Underperform from Buy and also double downgraded IFF (IFF) to Underperform. ShowHide Related Items >><< - 01/03/23
- Brenntag terminates preliminary discussions with Univar
- 01/03/23
- Univar confirms Brenntag talks ended, weighing other interest
- 12/15/22
- Univar and Kalsec expand distribution partnership for ingredient solutions
- 11/30/22
- Engine Capital sends letter to Univar board requesting initiation of review
- 11/29/22
- Livent and NTU Singapore announce research collaboration
- 11/25/22
- Livent falls -10.6%
- 11/25/22
- Livent falls -6.0%
- 09/12/22
- Livent falls -6.6%
- 12/20/22
- IFF sells Savory Solutions Group to PAI Partners
- 12/07/22
- IFF intends to reduce size of board to 10 from 14 directors
- 12/07/22
- IFF expects to announce three non-core divestitures by end of 1Q23
- 11/22/22
- IFF and Salus Optima announce partnership
- 12/01/22
- Eastman Chemical raises quarterly dividend 4% to 79c per share
- 09/22/22
- Eastman Chemical signs supply agreement for recycling facility in France
- 09/22/22
- Eastman Chemical signs supply agreement for recycling facility in France
- 09/20/22
- Eastman to provide recyclable packaging to Johnson & Johnson's MedTech
- 10/26/22
- Novonix appoints Daniel Akerson, Ron Edmonds to board of directors
- 10/20/22
- Dow Inc. expects dynamic macro environment in the near term
- 10/17/22
- Dow Inc. to accelerate sustainability targets the company set in 2020
- 09/14/22
- Dow an Mura plan to construct new facility at Bohlen
- 12/20/22
- Corteva Agriscience, Nevonex announce collaboration agreement
- 11/30/22
- Corteva to acquire Stoller Group for $1.2B
- 11/14/22
- Starboard takes stake in Wix.com, exits Elanco Animal Health
- 10/03/22
- Syngenta, Corteva sued by FTC for pay-to-black scheme
- 11/29/22
- Chemours 'tracking slightly below' low end of FY22 adjusted EBITDA, FCF guidance
- 11/14/22
- Greenlight takes new stake in Intel, exits position in Atlas Air
- 10/27/22
- Chemours to enter joint venture with BWT Fumatech Mobility
- 10/25/22
- Chemours backs FY22 adjusted EBITDA view $1.4B-$1.45B
- 01/11/23 BofA
- Chemours upgraded to Buy from Neutral at BofA
- 01/10/23 RBC Capital
- Chemours downgraded to Sector Perform from Outperform at RBC Capital
- 12/15/22 Citi
- Chemours price target raised to $33 from $30 at Citi
- 11/01/22 Credit Suisse
- Chemours initiated with an Underperform at Credit Suisse
- 01/11/23 BofA
- Eastman Chemical upgraded to Buy from Neutral at BofA
- 01/04/23 UBS
- Eastman Chemical price target raised to $108 from $96 at UBS
- 12/15/22 Citi
- Eastman Chemical price target raised to $90 from $75 at Citi
- 11/08/22 Tudor Pickering
- Eastman Chemical upgraded to Buy from Hold at Tudor Pickering
- 01/11/23 BofA
- Livent upgraded to Buy from Underperform at BofA
- 01/10/23 Deutsche Bank
- Livent price target lowered to $22 from $30 at Deutsche Bank
- 01/04/23 Vertical Research
- Livent upgraded to Buy from Hold at Vertical Research
- 12/15/22 Citi
- Livent price target lowered to $27 from $31 at Citi
- 01/11/23 BofA
- Dow Inc. upgraded to Neutral from Underperform at BofA
- 12/15/22 Citi
- Dow Inc. price target raised to $56 from $47 at Citi
- 10/21/22 Fermium Research
- Dow Inc. price target lowered to $50 from $60 at Fermium Research
- 10/21/22 Citi
- Dow Inc. price target raised to $47 from $45 at Citi
- 01/11/23 BofA
- Corteva upgraded to Neutral from Underperform at BofA
- 11/17/22 Barclays
- Corteva price target raised to $75 from $71 at Barclays
- 11/15/22 UBS
- Corteva downgraded to Neutral from Buy at UBS
- 11/15/22 Loop Capital
- Corteva downgraded to Hold from Buy at Loop Capital
- 01/11/23 BofA
- Univar downgraded to Underperform from Buy at BofA
- 01/03/23 Oddo BHF
- Brenntag upgraded to Outperform from Neutral at Oddo BHF
- 11/29/22 Deutsche Bank
- Univar buyout could bring 'substantial upside,' says Deutsche Bank
- 11/29/22 Citi
- Brenntag downgraded to Neutral from Buy at Citi
- 01/11/23 BofA
- IFF downgraded to Underperform from Buy at BofA
- 12/15/22 Citi
- IFF price target raised to $114 from $100 at Citi
- 12/12/22 Barclays
- IFF price target raised to $89 from $83 at Barclays
- 12/08/22 Wells Fargo
- IFF price target raised to $123 from $105 at Wells Fargo
- 11/01/22
- Univar sees FY22 adjusted EBITDA $1.050B-$1.070B
- 11/01/22
- Univar sees Q4 adjusted EBITDA $180M-$200M
- 11/01/22
- Univar reports Q3 EPS 78c, consensus 76c
- 08/01/22
- Univar sees FY22 adjusted EBITDA $1.040B-$1.080B
- 11/01/22
- Livent narrows FY22 revenue view to $815M-$845M from $800M-$860M
- 11/01/22
- Livent reports Q3 EPS 41c, consensus 40c
- 08/02/22
- Livent raises FY22 revenue to $800M-$860M from $755M-$835M
- 08/02/22
- Livent reports Q2 GAAP EPS 31c, consensus 29c
- 12/07/22
- IFF expects mid-single digit adjusted operating EBITDA growth in FY23
- 11/07/22
- IFF cuts FY22 revenue view to $12.4B-$12.5B from $12.6B-$13B
- 11/07/22
- IFF reports Q3 adjusted EPS ex-amortization $1.36, consensus $1.20
- 08/08/22
- IFF backs FY22 revenue view $12.6B-$13B, consensus $12.38B
- 10/27/22
- Eastman Chemical cuts FY22 EPS view to $8.05-$8.35 from $9.50-$10.00
- 10/27/22
- Eastman Chemical sees Q4 EPS $1.10-$1.40, consensus $1.82
- 10/27/22
- Eastman Chemical reports Q3 adjusted EPS $2.05, consensus $2.00
- 09/13/22
- Eastman Chemical reports preliminary Q3 adjusted EPS $2.00, consensus $2.60
- 10/20/22
- Dow Inc. reports Q3 operating EPS $1.11, consensus $1.08
- 09/14/22
- Dow Inc. sees $600M lower Q3 net sales compared to consensus
- 07/21/22
- Dow Inc. reports Q2 operating EPS $2.31, consensus $2.14
- 11/03/22
- Corteva backs FY22 adjusted EPS view $2.45-$2.60, consensus $2.57
- 11/03/22
- Corteva reports Q3 adjusted EPS (12c), consensus (23c)
- 11/03/22
- Notable companies reporting after market close
- 08/04/22
- Corteva raises FY22 operating EPS view to $2.45-$2.60 from $2.35-$2.55
- 10/25/22
- Chemours reports Q3 adjusted EPS $1.24, consensus $1.07
- 07/28/22
- Chemours now sees FY22 adjusted EBITDA at high end of $1.475B-$1.575B range
- 07/28/22
- Chemours reports Q2 adjusted EPS $1.89, consensus $1.43
- 01/03/23
- What You Missed On Wall Street On Tuesday
- 11/28/22
- What You Missed On Wall Street On Monday
- 11/28/22
- What You Missed On Wall Street This Morning
- 10/21/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 10/24/22
- Here's what Wall St. experts are saying about these automakers ahead of earnings
- 10/17/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 10/03/22
- What You Missed On Wall Street On Monday
- 10/03/22
- What You Missed On Wall Street This Morning
- 09/20/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 09/13/22
- What You Missed On Wall Street On Tuesday
- 09/13/22
- What You Missed On Wall Street This Morning
- 09/13/22
- Fly Intel: Pre-market Movers
- 09/14/22
- What You Missed On Wall Street On Wednesday
- 09/14/22
- What You Missed On Wall Street This Morning
- 09/14/22
- Fly Intel: Pre-market Movers
- 11/15/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 08/08/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 08/04/22
- Fly Intel: After-Hours Movers
- 10/25/22
- Fly Intel: After-Hours Movers
- 07/28/22
- Fly Intel: After-Hours Movers
- 01/09/23
- Livent call volume above normal and directionally bullish
- 11/15/22
- Livent put volume heavy and directionally bearish
- 11/11/22
- Livent call volume above normal and directionally bullish
- 11/01/22
- Livent options imply 7.6% move in share price post-earnings
- 01/10/23
- Dow Chemical put volume heavy and directionally bearish
- 01/04/23
- Dow Chemical call volume above normal and directionally bullish
- 11/11/22
- Early notable gainers among liquid option names on November 11th
- 09/14/22
- Dow Chemical put volume heavy and directionally bearish
- 09/13/22
- Early notable gainers among liquid option names on September 13th
- 08/05/22
- Early notable gainers among liquid option names on August 5th
- 10/25/22
- Chemours options imply 6.6% move in share price post-earnings
|
|
Downgrade
|
BofA analyst Steve Byrne… BofA analyst Steve Byrne downgraded Univar to Underperform from Buy. ShowHide Related Items >><< - 01/03/23
- Brenntag terminates preliminary discussions with Univar
- 01/03/23
- Univar confirms Brenntag talks ended, weighing other interest
- 12/15/22
- Univar and Kalsec expand distribution partnership for ingredient solutions
- 11/30/22
- Engine Capital sends letter to Univar board requesting initiation of review
- 01/03/23 Oddo BHF
- Brenntag upgraded to Outperform from Neutral at Oddo BHF
- 11/29/22 Deutsche Bank
- Univar buyout could bring 'substantial upside,' says Deutsche Bank
- 11/29/22 Citi
- Brenntag downgraded to Neutral from Buy at Citi
- 11/28/22 Jefferies
- Brenntag a 'logical suitor' for Univar, says Jefferies
- 11/01/22
- Univar sees FY22 adjusted EBITDA $1.050B-$1.070B
- 11/01/22
- Univar sees Q4 adjusted EBITDA $180M-$200M
- 11/01/22
- Univar reports Q3 EPS 78c, consensus 76c
- 08/01/22
- Univar sees FY22 adjusted EBITDA $1.040B-$1.080B
- 01/03/23
- What You Missed On Wall Street On Tuesday
- 11/28/22
- What You Missed On Wall Street On Monday
- 11/28/22
- What You Missed On Wall Street This Morning
- 10/21/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
|
|
Initiation
|
Goldman Sachs analyst… Goldman Sachs analyst Suhasini Varanasi reinstated coverage of Brenntag with a Buy rating and EUR 88 price target. The analyst states that while she expect a slowdown in growth and contraction in margins in 2023, she also believes that this has been largely priced in as Brenntag is trading close to a trough price-to-earnings multiple of 10-times her 2023 estimates. ShowHide Related Items >><< - 01/03/23
- Brenntag terminates preliminary discussions with Univar
- 01/03/23
- Univar confirms Brenntag talks ended, weighing other interest
- 11/28/22
- Univar confirms preliminary indication of interest from Brenntag
- 11/25/22
- Brenntag says in preliminary talks to acquire Univar
- 01/03/23 Oddo BHF
- Brenntag upgraded to Outperform from Neutral at Oddo BHF
- 11/29/22 Deutsche Bank
- Univar buyout could bring 'substantial upside,' says Deutsche Bank
- 11/29/22 Citi
- Brenntag downgraded to Neutral from Buy at Citi
- 11/28/22 Jefferies
- Brenntag a 'logical suitor' for Univar, says Jefferies
- 11/28/22
- What You Missed On Wall Street On Monday
- 11/28/22
- What You Missed On Wall Street This Morning
|
